Table 3.
Relationship between reduced glutathione (GSH) (µmol/mL) and other demographic characteristics of the studied population.
| Result | N | Mean | SD | Median | IQR | P-value |
|---|---|---|---|---|---|---|
| Gender | 0.238 | |||||
| Male | 68 | 110.63 | 30.47 | 107.61 | 41.64 | |
| Female | 58 | 106.33 | 41.50 | 98.12 | 38.86 | |
| Age | 0.126 | |||||
| 19–59 years | 63 | 114.30 | 38.30 | 110.68 | 46.41 | |
| 60–86 years | 63 | 102.99 | 32.62 | 96.87 | 33.26 | |
| Hospitalization sector | 0.511 | |||||
| Clinics | 61 | 109.34 | 32.99 | 104.37 | 41.30 | |
| ICU | 65 | 108.00 | 38.64 | 104.96 | 37.83 | |
| Hospitalization length | 0.741 | |||||
| ≤1 week | 49 | 107.94 | 30.45 | 104.37 | 40.85 | |
| >1 week | 77 | 109.10 | 39.13 | 104.96 | 39.96 | |
| SpO2 | 0.882 | |||||
| <88 | 26 | 105.46 | 29.09 | 114.69 | 35.97 | |
| 88–90 | 16 | 113.90 | 39.86 | 106.20 | 42.10 | |
| >90 | 84 | 108.64 | 37.26 | 98.30 | 43.26 | |
Wilcoxon test.